• 제목/요약/키워드: probiotic safety

검색결과 73건 처리시간 0.023초

Safety Assessment of Potential Lactic Acid Bacteria Bifidobacterium longum SPM1205 Isolated from Healthy Koreans

  • Choi Sung Sook;Kang Byung Yong;Chung Myung Jun;Kim Soo Dong;Park So Hee;Kim Jung Soo;Kang Chin Yang;Ha Nam Joo
    • Journal of Microbiology
    • /
    • 제43권6호
    • /
    • pp.493-498
    • /
    • 2005
  • The safety assessment of Bifidobacterium longum SPM1205 isolated from healthy Koreans and this strain's inhibitory effects on fecal harmful enzymes of intestinal microflora were investigated. The overall safety of this strain was investigated during a feeding trial. Groups of SD rats were orally administered a test strain or commercial reference strain B. longum $1\times10^9\;CFU/kg$ body weight/day for four weeks. Throughout this time, their feed intake, water intake and live body weight were monitored. Fecal samples were periodically collected to test harmful enzyme activities of intestinal microflora. At the end of the four-week observation period, samples of blood, liver, spleen, kidney, and gut tissues were collected to determine for hematological parameters and histological differences. The results obtained in this experiment demonstrated that four weeks of consumption of this Bifidobacterium strain had no adverse effects on rat's general health status, blood biochemical parameters or histology. Therefore, it is likely to be safe for human use. Fecal harmful enzymes such as $\beta-glucosidase,\;\beta-glucuronidase$, tryptophanase and urease, were effectively inhibited during the administration of the B. longum SPM1205. These results suggested that this B. longum SPM 1205 could be used for humans as a probiotic strain.

The in vitro and in vivo Safety Evaluation of Lactobacillus acidophilus IDCC 3302

  • Bang, Won Yeong;Chae, Seung A;Ban, O-Hyun;Oh, Sangki;Park, Chanmi;Lee, Minjee;Shin, Minhye;Yang, Jungwoo;Jung, Young Hoon
    • 한국미생물·생명공학회지
    • /
    • 제49권1호
    • /
    • pp.39-44
    • /
    • 2021
  • As consumption of healthy foods continues to garner remarkable public attention, ensuring probiotic safety has become a priority. In this study, the safety of Lactobacillus acidophilus IDCC 3302 was assessed in vitro and in vivo. L. acidophilus IDCC 3302 showed negative results for hemolytic and β-glucuronidase activities. The whole-genome analysis (WGA) revealed that L. acidophilus IDCC 3302 did not possess antibiotic resistance or virulence genes. The minimal inhibitory concentrations of L. acidophilus IDCC 3302 confirmed its safety concerning antibiotic resistance. Furthermore, L. acidophilus IDCC 3302 was demonstrated to be nontoxic in the oral toxicity test in rats. Therefore, the results suggested that L. acidophilus IDCC 3302 might be safe for human consumption.

Safety Assessment of Lactobacillus fermentum PL9005, a Potential Probiotic Lactic Acid Bacterium, in Mice

  • PARK JONG-HWAN;LEE YEONHEE;MOON ENPYO;SEOK SEUNG-HYEOK;BAEK MIN-WON;LEE HUI-YOUNG;KIM DONG-JAE;KIM CHANG-HWAN;PARK JAE-HAK
    • Journal of Microbiology and Biotechnology
    • /
    • 제15권3호
    • /
    • pp.603-608
    • /
    • 2005
  • We recently isolated a novel probiotic strain, Lactobacillus fermentum PL9005 (KCCM-10250), from infant feces and showed that it had a potential immunoenhancing effect. In the present study, a safety assessment of the bacteria was performed using a BALB/c mouse model. Mice were administered with L. fermentum PL9005 daily for 28 days. There were no detectable changes in body weight, feed intake, or clinical signs, and no significant difference in hematological parameters or blood biochemistry between the L. fermentum PL9005-fed and control groups. Bacterial translocation was detected in the mesenteric lymph nodes, liver, and spleen of some mice with and without L. fermentum PL9005 feeding, however, the organisms were not related to ingestion of L. fermentum PL9005; this was confirmed by PCR using a species-specific primer. No gross lesions were detected in the liver, spleen, or intestine of L. fermentum PL9005-fed or control mice. Mucosal thickness in the ileum, cecum, and colon of L. fermentum PL9005-fed mice was not significantly different from that of corresponding organs in control mice. No inflammation or epithelial cell degeneration in the intestines was observed in any mice. These results indicate that ingestion of L. fermentum PL9005 is safe in mice and can be applied in the functional food market.

멸치 젓갈로부터 분리된 젖산세균의 프로바이오틱 특성 및 안전성 평가 (Probiotic properties and safety assessment of lactic acid bacteria isolated from salt-fermented anchovy)

  • 임은서;김영목;이은우
    • 한국식품과학회지
    • /
    • 제48권4호
    • /
    • pp.306-316
    • /
    • 2016
  • 멸치 젓갈로부터 분리한 젖산세균을 대상으로 프로바이오틱 균주로서의 기능적 특성과 안전성을 평가하였다. 분리된 균주는 생화학적 특성과 당 발효능 및 염기순서 분석을 통해 Enterococcus faecium AJ06, Leuconostoc mesenteroides AJ13, Pediococcus halophilus AJ22, Lactobacillus sakei AJ29 및 Pediococcus pentosaceus AJ35로 동정되었다. AJ06, AJ22 및 AJ29 균주들은 펩신이 첨가된 인공 위액 및 쓸개즙액에서 강한 저항성을 나타내었고, taurocholic acid 혹은 taurodeoxycholic acid가 첨가된 MRS 한천 평판 배지 상에서 쓸개즙분해효소를 생산하였다. 특히, Caco-2 세포에 대한 높은 부착능과 다양한 항생제에 대한 저항성을 나타낸 AJ22와 AJ29 균주는 항균물질 생산으로 인해 식중독균의 증식을 효과적으로 저해하였다. 이들 균주는 혈액 한천 평판배지 상에서 알파 및 베타용혈독을 나타내지 않았고, 아미노산 전구체가 함유된 MRS 액상배지 내에서 생체 아민을 생산하지 않았으며, Salmonella Typhimurium TA98 and TA100 균주에 대한 돌연변이도 유발하지 않았다.

편리성 및 저장성이 증진된 구형과립 요구르트 제조 (Production of spherical granule type yogurt with improving convenience and preservation)

  • 신명곤
    • 한국식품저장유통학회지
    • /
    • 제24권5호
    • /
    • pp.559-564
    • /
    • 2017
  • Probiotics로 알려진 유산균을 다량 포함하고 있으며 우유가 가지고 있는 영양성분을 함유한 액상형 요구르트를 사용하여, 저장성은 높지만 편리성이 낮은 분말형 요구르트의 단점을 개선한, 유동성 및 용해성이 우수한 구형과립 요구르트를 제조하였다. 구형과립 요구르트의 유동층코팅기 최적 제조조건은 반응표면분석방법(RSM design)을 이용하여 설정하였으며, feeding rate(FR) 0.54 mL/min, atomization air pressure(AP) 2.64 bar, product temperature(PT) $58.18^{\circ}C$의 유동층코팅기 운영조건하에서 최대회수율은 79.42%로 예측되었다. 유동층코팅기의 버텀스프레이 방식으로 제조된 구형과립 요구르트는 6-7 log CFU/g의 많은 유산균을 가지고 있었으며, 특히 상대습도 75% 및 저장온도 $25^{\circ}C$ 조건하에서 4개월 동안 유산균수의 감소가 아주 미미하여, 저장성 및 편리성이 증진된 새로운 형태의 유산균 제품 개발에 대한 가능성을 보여주었다.

프로바이오틱스에 의한 알레르기 질환 제어 및 안전성 (Control of Allergy with Probiotics and Its Safety)

  • 이예원;윤요한
    • Journal of Dairy Science and Biotechnology
    • /
    • 제38권1호
    • /
    • pp.19-26
    • /
    • 2020
  • Allergic diseases, including atopic dermatitis, asthma, allergic rhinitis, and food allergies, could be caused by dysbiosis that results in an immune system imbalance. The incidence of allergic diseases has been increasing and they are now one of the most common diseases throughout the world. Recently, probiotics have been suggested as an alternative intervention for the prevention and treatment of allergic diseases. Probiotics are endogenous microflora with functional effects within hosts. They have various clinical and immunological capacities and have recently been considered as a supplement for the treatment and prevention of allergic diseases. Probiotic bacteria modulate immune cells such as Th1, Th2, and regulatory T cells that are correlated with protection against atopic dermatitis, however, safety concerns for the use of probiotics have been raised. Therefore, further research is needed to clarify the efficacy and safety of probiotics in the treatment of allergic diseases.

Safety Assessment of Commercial Enterococcus Probiotics in Korea

  • Lee, Ki-Eun;Lee, Min-Young;Lee, Yeon-Hee
    • Journal of Microbiology and Biotechnology
    • /
    • 제18권5호
    • /
    • pp.942-945
    • /
    • 2008
  • There have been concerns about possible pathogenicity and antimicrobial resistance in Enterococcus, which constitute more than 50% of probiotics in the worldwide market. In this study, Enterococcus in sixteen products manufactured by ten different companies was tested for the presence of six virulence genes and two vancomycin resistance genes. Results in this study showed the safety of Enterococcus on the Korean market and the importance of screening vanA, vanE, agg, cylA, esp, and gelE. Pulse-field gel electrophoresis showed that the sixteen isolates tested in this study are originated from three strains.

Binding of Aflatoxin G1, G2 and B2 by Probiotic Lactobacillus spp.

  • Byun, J.R.;Yoon, Y.H.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제16권11호
    • /
    • pp.1686-1689
    • /
    • 2003
  • The ability of ten probiotic bacteria to bind a common food carcinogen aflatoxin $G_1$,$G_2$ and $B_2$ was assessed. The strains were incubated in vitro with aflatoxins and the toxin residues in the supernatant were measured using high performance liquid chromatography. The aflatoxin $G_1$ binding capacity of the strains was found to strain dependent, most efficient binding of AF$G_1$ was observed by L. acidophilus CU028 and L. brevis CU06 which bound approximately 50%. L. acidophilus CU028 was capable of bind approximately 67% of AF$G_2$, difference in their binding ability showed statistical significance (p>0.05). L. acidophilus CU028 and L. helveticus CU 631 were the best binders and the strains were observed to possess variable AF$B_2$-binding ability in the range was from 38.0% to 55.9%. Lactobacillus acidophilus CU028 was the best common binders of the three types of food carcinogen aflatoxins. The application of binding phenomenon in the removal of mycotoxins from contaminated feeds is urgently needed to improve the safety of feeds.

Lactic Acid Bacteria from Gamecock and Goat Originating from Phitsanulok, Thailand: Isolation, Identification, Technological Properties and Probiotic Potential

  • Hwanhlem, Noraphat;Salaipeth, Lakha;Charoensook, Rangsun;Kanjan, Pochanart;Maneerat, Suppasil
    • Journal of Microbiology and Biotechnology
    • /
    • 제32권3호
    • /
    • pp.355-364
    • /
    • 2022
  • From independent swab samples of the cloaca of indigenous gamecocks (CIG), anus of healthy baby goats (AHG), and vagina of goats (VG) originating from Phitsanulok, Thailand, a total of 263 isolates of lactic acid bacteria (LAB) were collected. Only three isolates, designated C707, G502, and V202, isolated from CIG, AHG, and VG, respectively, exhibited an excellent inhibitory zone diameter against foodborne pathogenic bacteria when evaluated by agar spot test. Isolates C707 and G502 were identified as Enterococcus faecium, whereas V202 was identified as Pediococcus acidilactici, based on 16S rRNA sequence analysis. When foodborne pathogenic bacteria were co-cultured with chosen LAB in mixed BHI-MRS broth at 39℃, their growth was suppressed. These LAB were found to be capable of surviving in simulated stomach conditions. Only the isolate G502 was able to survive in the conditions of simulated intestinal juice. This research suggests that selected LAB could be used as a food/feed supplement to reduce foodborne pathogenic bacteria and improve the safety of animal-based food or feed.